Mesothelioma: A Review

Frank Edmund Mott

Research output: Contribution to journalReview articlepeer-review

53 Scopus citations


Mesothelioma is an insidious disease with long latency after asbestos exposure. New cases are continually diagnosed, although levels are declining with recognition of the asbestos risk and efforts to remove asbestos from the workplace. Treatment for early stage disease with surgery and radiation is potentially curative, but many patients either are too ill to undergo aggressive surgery or present with advanced disease. Chemotherapy with cisplatin and pemetrexed is considered standard, although relapse is common. Second-line therapy is disappointing. New targeted therapies may pose promise and are being addressed in various clinical trial settings. Palliative care remains an important component of the management of this devastating illness.

Original languageEnglish (US)
Pages (from-to)70-79
Number of pages10
JournalOchsner Journal
Issue number1
StatePublished - Mar 26 2012


  • Asbestos
  • Diagnosis
  • Malignant pleural mesothelioma
  • Targeted therapies
  • Treatment

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Mesothelioma: A Review'. Together they form a unique fingerprint.

Cite this